The tablets are a potent diuretic intended for the treatment of edema.
The new treatment represents the first approved generic form of brand-name Edecrin tablets, which are produced by Canada-based Valeant Pharmaceuticals.
Edenbridge Pharmaceuticals, headquartered in Parsippany, N.J., plans to launch the ethacrynic acid tablets as soon as possible.
More articles on the drug market:
Sanofi, U.S. Army partner to speed up Zika vaccine development
Drugmakers hesitant to let generic rival Teva join PhRMA
Viewpoint: How drug coupons keep prices high
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
